Sabra Healthcare REIT had its Relative Strength (RS) Rating upgraded from 68 to 72 Thursday — a welcome improvement, but still below the 80 or better score you look for.
IBD's unique rating measures price action with a 1 (worst) to 99 (best) score. The grade shows how a stock's price performance over the last 52 weeks holds up against all the other stocks in our database.
History shows that the best-performing stocks tend to have an RS Rating of over 80 as they launch their biggest climbs. See if Sabra Healthcare REIT can continue to rebound and hit that benchmark.
Can You Really Time The Stock Market?
Sabra Healthcare REIT is not currently offering a proper buying opportunity. See if the stock goes on to form a sound pattern that could ignite a new run.
Taking a look at top and bottom line numbers, Sabra Healthcare REIT has posted three quarters of accelerating earnings growth. Sales growth has also moved higher over the same time frame.
The company earns the No. 17 rank among its peers in the Finance-Property REITs industry group. Equinix, American Healthcare REIT and American Assets Trust are among the top 5 highly rated stocks within the group.
RELATED:
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
